全文获取类型
收费全文 | 3697篇 |
免费 | 215篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 86篇 |
妇产科学 | 85篇 |
基础医学 | 396篇 |
口腔科学 | 75篇 |
临床医学 | 262篇 |
内科学 | 1177篇 |
皮肤病学 | 24篇 |
神经病学 | 328篇 |
特种医学 | 115篇 |
外科学 | 654篇 |
综合类 | 9篇 |
预防医学 | 76篇 |
眼科学 | 25篇 |
药学 | 186篇 |
中国医学 | 21篇 |
肿瘤学 | 379篇 |
出版年
2023年 | 19篇 |
2022年 | 40篇 |
2021年 | 99篇 |
2020年 | 41篇 |
2019年 | 58篇 |
2018年 | 95篇 |
2017年 | 70篇 |
2016年 | 81篇 |
2015年 | 107篇 |
2014年 | 117篇 |
2013年 | 163篇 |
2012年 | 259篇 |
2011年 | 256篇 |
2010年 | 150篇 |
2009年 | 127篇 |
2008年 | 204篇 |
2007年 | 254篇 |
2006年 | 238篇 |
2005年 | 237篇 |
2004年 | 228篇 |
2003年 | 224篇 |
2002年 | 246篇 |
2001年 | 46篇 |
2000年 | 49篇 |
1999年 | 40篇 |
1998年 | 59篇 |
1997年 | 48篇 |
1996年 | 48篇 |
1995年 | 47篇 |
1994年 | 25篇 |
1993年 | 28篇 |
1992年 | 25篇 |
1991年 | 28篇 |
1990年 | 20篇 |
1989年 | 27篇 |
1988年 | 20篇 |
1987年 | 20篇 |
1986年 | 10篇 |
1985年 | 19篇 |
1984年 | 17篇 |
1983年 | 8篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1980年 | 9篇 |
1979年 | 3篇 |
1978年 | 6篇 |
1977年 | 5篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1969年 | 3篇 |
排序方式: 共有3956条查询结果,搜索用时 46 毫秒
991.
992.
Yoneyama M Nakamichi N Fukui M Kitayama T Georgiev DD Makanga JO Nakamura N Taniura H Yoneda Y 《Journal of neuroscience research》2008,86(11):2392-2402
993.
994.
Tamaki M Nakashima M Nishiyama R Ikeda H Hiura M Kanaoka T Nakano T Hayashi T Ogawa O 《Hinyokika kiyo. Acta urologica Japonica》2008,54(6):435-445
We compared the usefulness of Eviprostat tablet, a therapeutic agent for benign prostatic hyperplasia (BPH), and EVI-F tablet, a new formulation of Eviprostat containing two times more active ingredients (Chimaphila umbellata extract, Populus tremula extract, Pulsatilla pratensis extract, Equisetum arvense extract and purified wheat germ oil) and consequently designed to reduce the number of tablets per dose by half. In this study, patients with BPH were randomly assigned to either Eviprostat group (6 tabs/day) or EVI-F group (3 tabs/day) using the envelope method. The clinical efficacy of these two drugs were evaluated by the International Prostate Symptom Score (IPSS) and QOL score at the end of the treatment period, and their safety was evaluated by the incidence of side effects. Based on the clinical study guidelines for dysuria, the change in the IPSS total score and QOL score were comparable to the previously reported data for other treatment agents for BPH, and these indices showed gradual improvement with the treatment period. Both treatments were well tolerated. The clinical usefulness of the monotherapy with EVI-F tablet or Eviprostat tablet was reasonably demonstrated in this study. Furthermore, both treatments reduced nocturia, which has an impact on the QOL of patients with BPH. 相似文献
995.
Hirabayashi Y Otsuka Y Taira K Shinohara T Kikuchi Y Shimada N Kono R Tamai K Inoue S Seo N 《Masui. The Japanese journal of anesthesiology》2008,57(8):1026-1030
BACKGROUND: We described an early experience of Airtraq laryngoscope in 20 patients receiving general anesthesia. METHODS: In all, 2 staff anesthesiologists, 3 anesthesia residents and 10 non-anesthesia residents performed endotracheal intubation with 14 polyvinyl chloride tubes with inside diameter of 7-8 mm, 5 double lumen 37-F tubes and 1 preformed nasotracheal tube. RESULTS: Every endotracheal intubation was achieved at the first trial, and the mean time to secure the airway was 46 +/- 18 seconds. CONCLUSIONS: Airtraq laryngoscope is a useful novel device for tracheal intubation. 相似文献
996.
Tokojima M Ashitani J Matsumoto N Nakazato M 《Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases》2007,81(5):582-585
A 38 year-old woman admitted for bilateral infiltrates with a cavity and treated diabetic ketoacidosis and elevated inflammatory reaction in clinical examination was found in transbronchial lung biopsy specimens to have bilateral pulmonary mucormycosis. We controlled blood glucose with insulin and removed bilateral pulmonary lesions separately. Pulmonary mucormycosis with diabetic ketoacidosis is a rare but fatal fungal infection. Early diagnosis, intensive insulin therapy, and surgical resection may save patients with pulmonary mucormycosis even if lesions are bilateral. 相似文献
997.
998.
Ganglioside mimicry and peripheral nerve disease 总被引:1,自引:0,他引:1
Yuki N 《Muscle & nerve》2007,35(6):691-711
Four criteria must be satisfied to conclude that a given microorganism causes Guillain-Barré (GBS) or Fisher (FS) syndrome associated with anti-ganglioside antibodies: (1) an epidemiological association between the infecting microbe and GBS or FS; (2) isolation in the acute progressive phase of illness of that microorganism from GBS or FS patients with associated anti-ganglioside IgG antibodies; (3) identification of a microbial ganglioside mimic; and (4) a GBS or FS with associated anti-ganglioside antibodies model produced by sensitization with the microbe itself or its component, as well as with ganglioside. Campylobacter jejuni is a definitive causative microorganism of acute motor axonal neuropathy and may cause FS and related conditions. Haemophilus influenzae and Mycoplasma pneumoniae are possible causative microorganisms of acute motor axonal neuropathy or FS. Acute and chronic inflammatory demyelinating polyneuropathies may be produced by mechanisms other than ganglioside mimicry. 相似文献
999.
Furukawa N Miyamura N Nishida K Motoshima H Taketa K Araki E 《Diabetes research and clinical practice》2007,75(3):366-367
The insulin autoimmune syndrome is characterized as producing polyclonal or monoclonal anti-insulin autoantibodies in a patient with no previous history of exposure to exogenous insulin. The patient is 44-year-old Japanese woman and she had symptoms of hypoglycaemia without exposure to exogenous insulin. The patient was considered to have IAS because high titre of anti-insulin autoantibodies (96-98%: bound/total) were found in her serum. Her HLA DR beta1 DNA sequences analysis revealed that she has the DRB1(*)0406 and DRB1(*)0901. Our patient have been taken alpha lipoic acid (ALA) before onset. SH group compounds are known to play an important role in the pathogenesis of IAS, and ALA contains SH. From these data, we propose the possibility of the correlation between pathogenesis of IAS and ALA, and it will be important to pay attention for ALA as a cause of hypoglycemia in such cases. 相似文献
1000.
Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat 总被引:2,自引:0,他引:2
Abe W Ikejima K Lang T Okumura K Enomoto N Kitamura T Takei Y Sato N 《Journal of hepatology》2007,46(2):286-294
BACKGROUND/AIMS: In this study, we investigated the effect of dalteparin sodium, a low molecular weight (LMW)-heparin, on hepatic fibrogenesis caused by chronic carbon tetrachloride (CCl4) administration in the rat. METHODS: Female Wistar rats were given a single, or repeated intraperitoneal injections of CCl4 (1ml/kg, twice per week) and dalteparin (50IU/kg, daily) for 7 weeks. RESULTS: Dalteparin did not prevent acute CCl4-induced hepatic necrosis and elevation in serum aminotransferases levels; however, proliferating cell nuclear antigen (PCNA)-positive hepatocytes were dramatically increased 24h after simultaneous administration of CCl4 and dalteparin. Interestingly, serum hepatocyte growth factor (HGF) levels 12h after injection of CCl4 were almost doubled when dalteparin was given simultaneously. Hepatic fibrosis following 7-week CCl4 treatment was markedly ameliorated by daily co-administration of dalteparin. Indeed, dalteparin largely inhibited CCl4-induction of smooth muscle alpha-actin expression, alpha1(I)procollagen and transforming growth factor (TGF)-beta1 mRNA levels in the liver. Further, dalteparin blunted platelet-derived growth factor (PDGF)-induced increases in 5-bromo-2'deoxyuridine (BrdU) uptake in 3-day cultured hepatic stellate cells (HSCs) in a dose-dependent manner. CONCLUSIONS: Dalteparin enhances hepatic regeneration and minimizes hepatic fibrogenesis caused by chronic CCl4 treatment. The mechanism underlying these effects most likely involves both up-regulation of HGF and inhibition of HSC proliferation. 相似文献